Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Novavax, Inc. (NVAX)

-NasdaqGS
4.56 Up 0.06(1.33%) 4:00PM EDT
|After Hours : 4.56 0.00 (0.00%) 5:00PM EDT
Prev Close:4.50
Open:4.59
Bid:4.51 x 2100
Ask:4.65 x 500
1y Target Est:11.00
Beta:1.17
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:4.48 - 4.63
52wk Range:2.24 - 6.95
Volume:3,059,192
Avg Vol (3m):3,925,000
Market Cap:954.13M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXUp 1.33%954.13M
MRKDown 0.85%169.73B
NVSUp 0.26%214.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback